Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan Pantziarka

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Health Policy OPEN|April 13, 2026
Policy barriers to drug repurposing in Europe: different stakeholder perspectives identified during survey-based shortlisting of key challengesKristóf Gyöngyösi, Zsuzsanna Ida Petykó, Dalma Hosszú, et al.
British Journal of Pharmacology|November 7, 2025
The eyes of the beholder: Perceived barriers to successful drug repurposingZsuzsanna Ida Petykó, Dalma Hosszú, Marcell Csanádi, et al.
Eclinicalmedicine|April 28, 2025
Genetic predisposition in sarcomas: clinical implications and managementElizabeth A Connolly, Kjetil Boye, Sylvie Bonvalot, et al.
JCO Precision Oncology|September 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing ConsortiumAntonio Juan Ribelles, Arthur Felix, Nuria Benavent, et al.
Trials|February 2, 2024
Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocolMiriam Dixon-Zegeye, Rachel Shaw, Linda Collins, et al.
Ecancermedicalscience|December 21, 2016
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, MumbaiPan Pantziarka, Lisa Hutchinson, Nicolas André, et al.
Cancer Treatment Reviews|August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersSilvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium StatementDarrell Green, Roelof van Ewijk, Elisa Tirtei, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Health Policy OPEN|April 13, 2026
Policy barriers to drug repurposing in Europe: different stakeholder perspectives identified during survey-based shortlisting of key challengesKristóf Gyöngyösi, Zsuzsanna Ida Petykó, Dalma Hosszú, et al.
British Journal of Pharmacology|November 7, 2025
The eyes of the beholder: Perceived barriers to successful drug repurposingZsuzsanna Ida Petykó, Dalma Hosszú, Marcell Csanádi, et al.
Eclinicalmedicine|April 28, 2025
Genetic predisposition in sarcomas: clinical implications and managementElizabeth A Connolly, Kjetil Boye, Sylvie Bonvalot, et al.
JCO Precision Oncology|September 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing ConsortiumAntonio Juan Ribelles, Arthur Felix, Nuria Benavent, et al.
Trials|February 2, 2024
Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocolMiriam Dixon-Zegeye, Rachel Shaw, Linda Collins, et al.
Ecancermedicalscience|December 21, 2016
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, MumbaiPan Pantziarka, Lisa Hutchinson, Nicolas André, et al.
Cancer Treatment Reviews|August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersSilvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium StatementDarrell Green, Roelof van Ewijk, Elisa Tirtei, et al.
Pageof 6